Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
Market closed$0.249800$-0.004200 (-1.65%)After hours $0.252700 · +1.16%
Key statistics
Previous close$0.254000
Open$0.240100
Day high$0.251300
Day low$0.230000
52-week high$3.48
52-week low$0.215000
Market cap328.58K
Volume228.75K
Average volume3.71M
P/E ratio-0.02
Forward P/E—
EPS-14.23
Dividend yield0.00%
Market context
Why it moved
SCNI experienced a modest decline today likely driven by light selling pressure and low liquidity, as no significant company-specific catalysts or news were identified to support the prior session's price level.
What is happening
Recent company-specific developments and publisher coverage.
Pluang · May 15, 2026Scinai Immunotherapeutics leads key roundtable ...PR Newswire · April 24, 2026Scinai Immunotherapeutics Announces $2.61 Million Private Placement FinancingStock Titan · April 24, 2026Scinai raises $2.61M to expand drug manufacturing, fund programsPR Newswire · April 1, 2026Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm CollaborationNasdaq · March 16, 2026Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid PricePR Newswire · February 25, 2026Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish PlatformPR Newswire · December 2, 2025Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances Benzinga · April 24, 2026Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today Benzinga · April 24, 2026Scinai Immunotherapeutics Enters Securities Purchase Agreement For Up To 5.21M ADS And Warrants Priced At $0.48 Per Unit Benzinga · April 1, 2026Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY Benzinga · March 16, 2026Scinai Immunotherapeutics Receives Non-Compliance Notification From Nasdaq Benzinga · March 2, 2026Scinai Executes Second Amendment To Binding Option Agreement For Acquisition Of PinCell And Submits Revised Application Under European FENG SMART Path Program Benzinga · September 2, 2025Scinai Revenues For Six Months Ended Jun. 30 $773K vs $284K YoY Benzinga · August 21, 202512 Health Care Stocks Moving In Thursday's Pre-Market Session Benzinga · August 20, 202512 Health Care Stocks Moving In Wednesday's After-Market Session